Sonia T. Oskouei, PharmD, BCMAS, DPLA serves as Vice President of Biosimilars for Cardinal Health, where she is charged with leading the national biosimilars strategy across the organization. In her role, she leverages an enterprise perspective to maximize the value of biosimilars to enhance patient access to critical therapies while lowering the costs of high-quality care. Prior to Cardinal Health, Dr. Oskouei served as the Vice President of Innovation and Digital Health at Premier Inc. Within the provider-led organization, she led Premier’s national biosimilars strategy on behalf of 4,000 hospitals and 175,000 other provider types. Dr. Oskouei is an established thought leader with numerous publications, experience engaging with the FDA, and is an active member of industry organizations such as the Center for Biosimilars where she is currently serving on the Board of Advisors. Dr. Oskouei previously oversaw pharmacy purchasing and procurement for Novant Health, a four-state Integrated Delivery Network. She received her Doctor of Pharmacy from Belmont University, and completed post-graduate residencies in Clinical Pharmacy and Health System Pharmacy Administration. Dr. Oskouei is also a Board-Certified Medical Affairs Specialist and a Diplomate of the American Society of Health-System Pharmacists Leadership Academy.